# Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT

> **NCT01144754** · — · TERMINATED · sponsor: **Stanford University** · enrollment: 1 (actual)

## Conditions studied

- Lymphoma
- Non-Hodgkin's Lymphoma

## Interventions

- **DRUG:** Rituximab

## Key facts

- **NCT ID:** NCT01144754
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2009-02
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Low Accrual
- **Last updated:** 2016-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01144754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01144754, "Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01144754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*